Khoury GG - Search Results

1

Heterogeneity of chemosensitivity of metastatic cutaneous melanoma.

Cree IA, Neale MH, Myatt NE, de Takats PG, Hall P, Grant J, Kurbacher CM, Reinhold U, Neuber K, MacKie RM, Chana J, Weaver PC, Khoury GG, Sartori C, Andreotti PE. Cree IA, et al. Among authors: khoury gg. Anticancer Drugs. 1999 Jun;10(5):437-44. doi: 10.1097/00001813-199906000-00002. Anticancer Drugs. 1999. PMID: 10477162

2

Comparison of the ex vivo chemosensitivity of uveal and cutaneous melanoma.

Neale MH, Myatt NE, Khoury GG, Weaver P, Lamont A, Hungerford JL, Kurbacher CM, Hall P, Corrie PG, Cree IA. Neale MH, et al. Among authors: khoury gg. Melanoma Res. 2001 Dec;11(6):601-9. doi: 10.1097/00008390-200112000-00006. Melanoma Res. 2001. PMID: 11725206

3

Treatment of recurrent and metastatic carcinoma of cervix: a comparison of low dose methotrexate with adriamycin plus methotrexate.

Sabir AA, Khoury GG, Joslin CA, Head C. Sabir AA, et al. Among authors: khoury gg. Clin Oncol (R Coll Radiol). 1989 Nov;1(2):70-4. doi: 10.1016/s0936-6555(89)80038-x. Clin Oncol (R Coll Radiol). 1989. PMID: 2486483

4

Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial.

Seymour MT, Thompson LC, Wasan HS, Middleton G, Brewster AE, Shepherd SF, O'Mahony MS, Maughan TS, Parmar M, Langley RE; FOCUS2 Investigators; National Cancer Research Institute Colorectal Cancer Clinical Studies Group. Seymour MT, et al. Lancet. 2011 May 21;377(9779):1749-59. doi: 10.1016/S0140-6736(11)60399-1. Epub 2011 May 11. Lancet. 2011. PMID: 21570111 Free PMC article. Clinical Trial.

5

Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial.

Rustin GJ, van der Burg ME, Griffin CL, Guthrie D, Lamont A, Jayson GC, Kristensen G, Mediola C, Coens C, Qian W, Parmar MK, Swart AM; MRC OV05; EORTC 55955 investigators. Rustin GJ, et al. Lancet. 2010 Oct 2;376(9747):1155-63. doi: 10.1016/S0140-6736(10)61268-8. Lancet. 2010. PMID: 20888993 Free article. Clinical Trial.

6

Long term results of Cathetron high dose rate intracavitary radiotherapy in the treatment of carcinoma of the cervix.

Khoury GG, Bulman AS, Joslin CA. Khoury GG, et al. Br J Radiol. 1991 Nov;64(767):1036-43. doi: 10.1259/0007-1285-64-767-1036. Br J Radiol. 1991. PMID: 1742585 Review.

7

Cancer of the cervix in women under 40 years of age, a regional survey, 1975-1984.

Peel KR, Khoury GG, Joslin CA, O'Donovan PJ, Mgaya H, Keates G, Head C, Thorogood DJ. Peel KR, et al. Among authors: khoury gg. Br J Obstet Gynaecol. 1991 Oct;98(10):993-1000. doi: 10.1111/j.1471-0528.1991.tb15337.x. Br J Obstet Gynaecol. 1991. PMID: 1751446

8

Primary malignant melanoma of the uterine cervix.

Owens OJ, Pollard K, Khoury GG, Dyson JE, Jarvis GJ, Joslin CA. Owens OJ, et al. Among authors: khoury gg. Clin Radiol. 1988 May;39(3):336-8. doi: 10.1016/s0009-9260(88)80565-8. Clin Radiol. 1988. PMID: 3396293

9

Influence of HDR fractions and dose on the 5-year results and complications of cervix cancer.

Joslin CA, Kilara G, Khoury G. Joslin CA, et al. Sonderb Strahlenther Onkol. 1988;82:100-5. Sonderb Strahlenther Onkol. 1988. PMID: 3134703 No abstract available.

10

Flow cytofluorometric evidence for the differential radioresponsiveness of aneuploid and diploid cervix tumours.

Dyson JE, Joslin CA, Rothwell RI, Quirke P, Khoury GG, Bird CC. Dyson JE, et al. Among authors: khoury gg. Radiother Oncol. 1987 Mar;8(3):263-72. doi: 10.1016/s0167-8140(87)80249-9. Radiother Oncol. 1987. PMID: 3575788

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page